Johnson & Johnson is buying hair care products maker Vogue International for about $3.3 billion.
Privately-held Vogue also sells other personal care products.
The acquisition will give Johnson & Johnson the OGX collection of shampoos, conditioners, treatments, styling products, body care and bath products, the FX hair styling product line and the Proganix and Maui Moisture hair care lines.
Vogue’s hair care products are sold in the U.S. and 38 other countries.
Johnson & Johnson, based in New Brunswick, N.J., has brands including Neutrogena and Band-Aid.
The deal is expected to close in the third quarter.
Johnson & Johnson said that the transaction isn’t expected to impact its previously announced full-year sales and earnings forecasts.
J&J shares rose 47 cents to $113.25 in morning trading Thursday. Its shares are up more than 13 percent over the past year.
Source: Associated Press via Salt Lake Tribune
Novo Holdings has concluded the acquisition of all outstanding shares of commercial-stage biopharmaceutical company Paratek Pharmaceuticals for nearly $462m (€433.67m) to bolster its antimicrobial resistance (AMR) expertise. Paratek develops and commercialises new treatments for life-threatening ailments. Its speciality pharmaceutical platform aids in developing new therapeutics.
Glenmark Pharmaceuticals has signed a definitive agreement for the divestiture of a 75% stake in its division, Glenmark Life Sciences (GLS), to Indian company Nirma in a deal valued at Rs56.51bn ($679.85m). Glenmark Life Sciences focuses on producing active pharmaceutical ingredients (API).
Pierre-Alain Ruffieux, CEO of Lonza, will leave the Basel-based company at the end of September. According to the Swiss Contract Development and Manufacturing Organization (CDMO), the separation is by mutual agreement.
